Investing.com - Thermo Fisher Scientific (NYSE:TMO) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Thermo Fisher Scientific announced earnings per share of $5.76 on revenue of $9.33B. Analysts polled by Investing.com anticipated EPS of $4.68 on revenue of $8.33B.
Thermo Fisher Scientific shares are up 30% from the beginning of the year, still down 1.39% from its 52 week high of $616.93 set on September 24. They are outperforming the S&P 500 which is up 21.8% from the start of the year.
Thermo Fisher Scientific follows other major Healthcare sector earnings this month
Thermo Fisher Scientific's report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Abbott Labs had beat expectations on October 20 with third quarter EPS of $1.4 on revenue of $10.93B, compared to forecast for EPS of $0.9449 on revenue of $9.56B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar